Owens & Minor, Inc. (NYSE:OMI) Shares Sold by Corton Capital Inc.

Corton Capital Inc. decreased its position in Owens & Minor, Inc. (NYSE:OMI) by 15.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,130 shares of the company’s stock after selling 2,728 shares during the quarter. Corton Capital Inc.’s holdings in Owens & Minor were worth $198,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Waldron Private Wealth LLC purchased a new stake in Owens & Minor during the fourth quarter worth approximately $406,000. JPMorgan Chase & Co. lifted its position in shares of Owens & Minor by 68.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after buying an additional 152,999 shares during the last quarter. Advisors Preferred LLC lifted its position in shares of Owens & Minor by 173.9% during the 4th quarter. Advisors Preferred LLC now owns 84,305 shares of the company’s stock worth $1,083,000 after buying an additional 53,529 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Owens & Minor by 11.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 20,259 shares of the company’s stock valued at $265,000 after buying an additional 2,112 shares in the last quarter. Finally, Barclays PLC grew its position in shares of Owens & Minor by 354.8% in the 3rd quarter. Barclays PLC now owns 133,702 shares of the company’s stock valued at $2,099,000 after buying an additional 104,305 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Insider Buying and Selling at Owens & Minor

In related news, major shareholder Coliseum Capital Management, L purchased 160,000 shares of the stock in a transaction dated Thursday, April 3rd. The shares were acquired at an average cost of $8.53 per share, with a total value of $1,364,800.00. Following the purchase, the insider now directly owns 10,784,599 shares in the company, valued at $91,992,629.47. This trade represents a 1.51 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last 90 days, insiders have acquired 2,718,412 shares of company stock valued at $24,495,308. 3.69% of the stock is owned by corporate insiders.

Owens & Minor Trading Down 10.4 %

NYSE:OMI opened at $6.96 on Friday. Owens & Minor, Inc. has a 12-month low of $6.07 and a 12-month high of $21.02. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The stock’s 50 day simple moving average is $8.18 and its 200-day simple moving average is $10.85. The firm has a market cap of $537.31 million, a P/E ratio of -10.70, a PEG ratio of 0.20 and a beta of 1.38.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.03. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. During the same quarter in the prior year, the company posted $0.19 earnings per share. The business’s revenue was up .7% compared to the same quarter last year. Equities analysts anticipate that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor declared that its Board of Directors has authorized a stock repurchase program on Friday, February 28th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 13.6% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on OMI shares. UBS Group decreased their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Robert W. Baird raised their price target on Owens & Minor from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd. Citigroup decreased their price objective on Owens & Minor from $13.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, April 17th. Finally, JPMorgan Chase & Co. cut their target price on shares of Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a report on Monday, March 10th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $12.50.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.